Potentially inadequate medication in patients with myasthenia gravis

• Conditions: G70.0; Myasthenia gravis

• Registration Number: DRKS00033635
• Lead Sponsor: niversitätsmedizin Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-02-16
• Study Completion: 2024-05-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 85

Inclusion Criteria

Patients with clinically and instrumentally verified MG
- = 18 years of age
- Ability to consent or legal guardian with court authorisation for the area of responsibility

Exclusion Criteria

- Patients with unclear neuromuscular disease without the fulfilment of clinically and clinically and instrumentally definitive signs of MG
- <18 years of age
- Patient incapable of giving consent with a carer, without judicial authorisation for the area of responsibility

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of potentially inadequate medication in patients with myasthenia gravis and the risk factors for the occurrence of these medications.

Secondary Outcome Measures

Name	Time	Method
- Clinical outcome of patients with potentially inadequate medication.<br>- Relevance of potentially inadequate treatment in our cohort.<br>- The level of patient education regarding medication and potentially inadequate medication.